2022
DOI: 10.1007/s11282-022-00594-2
|View full text |Cite
|
Sign up to set email alerts
|

The effect of zoledronic acid and denosumab on the mandible and other bones: a 18F-NaF-PET study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…One review reported a case of almost normalization of bone metastases uptake after the introduction of denosumab, despite the rise in biological tumor markers ( 48 ). A more recent study compared the uptake intensity of 18 F-NaF between patients treated by denosumab and a control group using cervical vertebrae as a reference, showing no significant difference ( 49 ).…”
Section: Bone Scan: the Historical Cornerstone In The Management Of B...mentioning
confidence: 99%
“…One review reported a case of almost normalization of bone metastases uptake after the introduction of denosumab, despite the rise in biological tumor markers ( 48 ). A more recent study compared the uptake intensity of 18 F-NaF between patients treated by denosumab and a control group using cervical vertebrae as a reference, showing no significant difference ( 49 ).…”
Section: Bone Scan: the Historical Cornerstone In The Management Of B...mentioning
confidence: 99%